chr9-20715402-C-A

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BS1_Supporting

The NM_001375567.1(FOCAD):​c.49C>A​(p.Gln17Lys) variant causes a missense change. The variant allele was found at a frequency of 0.0000629 in 1,511,334 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. Q17Q) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000059 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000063 ( 0 hom. )

Consequence

FOCAD
NM_001375567.1 missense

Scores

2
7
7

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:3

Conservation

PhyloP100: 6.24

Publications

2 publications found
Variant links:
Genes affected
FOCAD (HGNC:23377): (focadhesin) Located in focal adhesion. [provided by Alliance of Genome Resources, Apr 2022]
FOCAD Gene-Disease associations (from GenCC):
  • liver disease, severe congenital
    Inheritance: AR Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0000592 (9/152122) while in subpopulation NFE AF = 0.000118 (8/68018). AF 95% confidence interval is 0.0000584. There are 0 homozygotes in GnomAd4. There are 4 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FOCADNM_001375567.1 linkc.49C>A p.Gln17Lys missense_variant Exon 2 of 44 ENST00000338382.11 NP_001362496.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FOCADENST00000338382.11 linkc.49C>A p.Gln17Lys missense_variant Exon 2 of 44 5 NM_001375567.1 ENSP00000344307.6 Q5VW36
FOCADENST00000380249.5 linkc.49C>A p.Gln17Lys missense_variant Exon 4 of 46 1 ENSP00000369599.1 Q5VW36

Frequencies

GnomAD3 genomes
AF:
0.0000592
AC:
9
AN:
152122
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000118
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000397
AC:
9
AN:
226494
AF XY:
0.0000647
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000854
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000633
AC:
86
AN:
1359212
Hom.:
0
Cov.:
29
AF XY:
0.0000699
AC XY:
47
AN XY:
672588
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31094
American (AMR)
AF:
0.00
AC:
0
AN:
38920
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
23754
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36738
South Asian (SAS)
AF:
0.00
AC:
0
AN:
65146
European-Finnish (FIN)
AF:
0.0000204
AC:
1
AN:
48936
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5398
European-Non Finnish (NFE)
AF:
0.0000787
AC:
83
AN:
1053994
Other (OTH)
AF:
0.0000362
AC:
2
AN:
55232
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.462
Heterozygous variant carriers
0
4
7
11
14
18
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000592
AC:
9
AN:
152122
Hom.:
0
Cov.:
32
AF XY:
0.0000538
AC XY:
4
AN XY:
74308
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41438
American (AMR)
AF:
0.00
AC:
0
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5202
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4816
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10592
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000118
AC:
8
AN:
68018
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000128
Hom.:
0
Bravo
AF:
0.0000642
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.0000412
AC:
5

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Jan 23, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.49C>A (p.Q17K) alteration is located in exon 4 (coding exon 1) of the FOCAD gene. This alteration results from a C to A substitution at nucleotide position 49, causing the glutamine (Q) at amino acid position 17 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

FOCAD-related disorder Uncertain:1
Mar 14, 2023
PreventionGenetics, part of Exact Sciences
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The FOCAD c.49C>A variant is predicted to result in the amino acid substitution p.Gln17Lys. To our knowledge, this variant has not been reported in the literature or in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -

not provided Uncertain:1
Oct 13, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces glutamine, which is neutral and polar, with lysine, which is basic and polar, at codon 17 of the FOCAD protein (p.Gln17Lys). This variant is present in population databases (rs201120976, gnomAD 0.009%). This variant has not been reported in the literature in individuals affected with FOCAD-related conditions. ClinVar contains an entry for this variant (Variation ID: 2636103). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.38
BayesDel_addAF
Benign
-0.12
T
BayesDel_noAF
Benign
-0.22
CADD
Pathogenic
26
DANN
Uncertain
1.0
Eigen
Uncertain
0.64
Eigen_PC
Pathogenic
0.68
FATHMM_MKL
Uncertain
0.96
D
M_CAP
Benign
0.018
T
MetaRNN
Uncertain
0.72
D;D
MetaSVM
Benign
-1.2
T
PhyloP100
6.2
PrimateAI
Uncertain
0.59
T
PROVEAN
Benign
-1.2
N;N
REVEL
Benign
0.23
Sift
Uncertain
0.026
D;D
Sift4G
Pathogenic
0.0
D;D
Vest4
0.87
MVP
0.47
MPC
0.026
ClinPred
0.37
T
GERP RS
5.8
gMVP
0.69
Mutation Taster
=88/12
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201120976; hg19: chr9-20715401; API